NCT06426693Recruiting
Craving Network Neurofeedback
Connectome-based Neurofeedback of the Craving Network to Reduce Food Cue Reactivity
Source: ClinicalTrials.gov · Last updated 3 Dec 2025
Brief summary (registry, in English)
This project tests whether individuals with overweight or obesity and high craving can learn to change their brain response to food cues using neurofeedback, to impact their craving and eating behavior.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 17 May 2024
- Start date
- 27 Nov 2024
- Primary completion date
- 31 Mar 2027
- Lead sponsor
- Yale University
- Diseases
- Obesity
- NCT number
- NCT06426693
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 27 Nov 2024 to the primary completion date, 31 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current or past 6 months use of anti-obesity medications
Other illness
- Current diagnosis of neurological or psychiatric disorder
- Obesity-related diseases such as type-2 diabetes
Other
- Weight-reduced state defined as \>10% weight reduction in the past 6 months.
- Nicotine use
- Contraindications to MRI
- Baseline scanning with motion \>0.15mm frame to frame displacement.
Who the study is looking for
- Ages 18 to 60 years
- Body mass index \>25 kg/m2
- \>2.37 Food Craving Inventory score
Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yale MRRC Anlyan Center Coordinator of this site? Confirm its status | New Haven | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.